Search research articles
Contact Us
Filters
Showing results (111-120 of 131) with videos related to
Page
of 14
Sort By:
Molecular Cancer Therapeutics
|
July 13, 2021
Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer
Tamara Mirzapoiazova, Gang Xiao, Bolot Mambetsariev, et al.
Nature Medicine
|
May 13, 2014
Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers
Francesca Cottini, Teru Hideshima, Chunxiao Xu, et al.
Molecular Cancer Therapeutics
|
April 4, 2022
Correction: Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer
Tamara Mirzapoiazova, Gang Xiao, Bolot Mambetsariev, et al.
Nature Medicine
|
February 25, 2026
Editorial Expression of Concern: Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers
Francesca Cottini, Teru Hideshima, Chunxiao Xu, et al.
British Journal of Cancer
|
June 5, 2021
Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM)
Moshe Lapidot, Abigail E Case, Ellen L Weisberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2009
Ethnic differences and functional analysis of MET mutations in lung cancer
Soundararajan Krishnaswamy, Rajani Kanteti, Jonathan S Duke-Cohan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2009
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia
Akinori Yoda, Yuka Yoda, Sabina Chiaretti, et al.
Blood
|
March 14, 2012
Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors
Margaret Nieborowska-Skorska, Piotr K Kopinski, Regina Ray, et al.
Nature Chemical Biology
|
October 3, 2017
Inhibition of USP10 induces degradation of oncogenic FLT3
Ellen L Weisberg, Nathan J Schauer, Jing Yang, et al.
Blood Cancer Journal
|
July 19, 2022
BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma
Ellen Weisberg, Basudev Chowdhury, Chengcheng Meng, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 131) with videos related to
Sort By:
Page
of 14
Molecular Cancer Therapeutics
|
July 13, 2021
Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer
Tamara Mirzapoiazova, Gang Xiao, Bolot Mambetsariev, et al.
Nature Medicine
|
May 13, 2014
Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers
Francesca Cottini, Teru Hideshima, Chunxiao Xu, et al.
Molecular Cancer Therapeutics
|
April 4, 2022
Correction: Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer
Tamara Mirzapoiazova, Gang Xiao, Bolot Mambetsariev, et al.
Nature Medicine
|
February 25, 2026
Editorial Expression of Concern: Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers
Francesca Cottini, Teru Hideshima, Chunxiao Xu, et al.
British Journal of Cancer
|
June 5, 2021
Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM)
Moshe Lapidot, Abigail E Case, Ellen L Weisberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 2009
Ethnic differences and functional analysis of MET mutations in lung cancer
Soundararajan Krishnaswamy, Rajani Kanteti, Jonathan S Duke-Cohan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2009
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia
Akinori Yoda, Yuka Yoda, Sabina Chiaretti, et al.
Blood
|
March 14, 2012
Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors
Margaret Nieborowska-Skorska, Piotr K Kopinski, Regina Ray, et al.
Nature Chemical Biology
|
October 3, 2017
Inhibition of USP10 induces degradation of oncogenic FLT3
Ellen L Weisberg, Nathan J Schauer, Jing Yang, et al.
Blood Cancer Journal
|
July 19, 2022
BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma
Ellen Weisberg, Basudev Chowdhury, Chengcheng Meng, et al.
Page
of 14